ISRG Intuitive Surgical, Inc. Company Research Saturday, January

New Post Public Reply Private Reply Replies (0) Message Board

Jan 11, 2014 at 11:30 PM

ISRG Intuitive Surgical, Inc. $ISRG Company Overview

Stock Message Board http://investorshangout.com/search?q=ISRG&...mp;yt1=Go!

Last Updated: Saturday, January 11, 2014 11:30:45 PM

Intuitive Surgical, Inc. ISRG Current Price and Quotes
Last Price 420.15
Previous Close 386.78 Open 386.47
Daily Range 424.58 - 385.27 52wk Range 585.67 - 351.14
Volume 1,496,469 Dividend N/A
Average Vol (3m) 462,467 Yield N/A
Intuitive Surgical, Inc. ISRG
Company Information

950 Kifer Road
Sunnyvale, CA 94086

Website: http://www.intuitivesurgical.com
Phone: (408) 523-2100

Intuitive Surgical, Inc. ISRG
Not Available

Intuitive Surgical, Inc. ISRG
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0001035267
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Intuitive Surgical, Inc. ISRG
ISRG Security Details

Share Structure

Market Value1 $14,160,637,360 a/o Jan 10, 2014
Shares Outstanding 38,064,183 a/o Oct 08, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders

Shareholders of Record 257 a/o Feb 06, 2009
Security Notes

New Issue=6-00 5,750,000 shs at $9 by Lehman Brothers et al.
Capital Change=shs decreased by 1 for 2 split. Pay date=07/01/2003.
Short Selling Data

Short Interest 2,638,387 (4.48%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)

Computershare Trust Company Inc.

Intuitive Surgical, Inc. ISRG Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 2,178,800 1,757,300 1,413,000 1,052,200
Cost of Revenue 608,500 483,500 383,000 301,100
Gross Profit 1,570,300 1,273,800 1,030,000 751,100
Operating Expenses

Research and Development 170,000 140,200 116,000 95,100
Sales, General and Admin. 522,200 438,800 358,800 278,600
Non-Recurring Items - - - -
Other - - - -
Operating Income 878,100 694,800 555,200 377,400
Income From Continuing Operations

Add'l Income/Expense Items 15,800 14,900 17,100 18,700
Earnings Before Interest and Tax 893,900 709,700 572,300 396,100
Interest Expense - - - -
Earnings Before Tax 893,900 709,700 572,300 396,100
Income Tax 237,300 214,600 190,500 163,500
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 656,600 495,100 381,800 232,600
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 656,600 495,100 381,800 232,600
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 656,600 495,100 381,800 232,600

Intuitive Surgical, Inc. ISRG Recent News

Jan 9, 2014 Database Study Shows Shorter Hospital Stay, Fewer Complications for Robotic-Assisted Prostate Surgery Versus Open Surgery
Jan 6, 2014 Study Results, Product Recalls, Progress on Environmental Goals, Shareholders Resolutions, and Product Launch - Research Report on Intuitive Surgical, Baxter, Thermo Fisher, DaVita, and Mindray
Dec 20, 2013 Upcoming Earnings, New Releases, Stock Movements, Quarterly Dividends and Repurchase Authorizations - Research Report on Intuitive Surgical, McKesson, AmerisourceBergen, Henry Schein, and Omnicare
Dec 16, 2013 Appointments, Employee Option Grants, Clinical Data Presentations, New Launches, and Scheduled Financial Results - Research Report on Intuitive, Alexion, Sequenom, AcelRx, and Arrowhead
Dec 10, 2013 Intuitive Surgical Reports New Employee Option Grants for December 2013
Dec 7, 2013 da Vinci Lawsuit News: Rottenstein Law Group LLP Comments on FDA Notice About Robot Failure During Surgery
Dec 6, 2013 Upcoming Presentations, Stock Price Movements, and Patent Challenge Settlements - Research Report on Johnson & Johnson, Alexion, Intuitive Surgical, Medivation, and Impax
Dec 4, 2013 As Da Vinci Robot Lawsuits Mount, Bernstein Liebhard LLP Comments on Latest Da Vinci Robot Instrument Recall
Nov 27, 2013 Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Says New Study Adds to Debate Surrounding Robotic Surgery
Nov 27, 2013 New Agreements and Stock Movements in Healthcare Companies - Research Report on Abbott, Thermo Fisher, Intuitive Surgical, Mindray, and Zeltiq

1
2
3
next >

ISRG Intuitive Surgical, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=ISRG&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ISRG/quote
Stock Chart http://www.otcmarkets.com/stock/ISRG/chart
Company Info http://www.otcmarkets.com/stock/ISRG/company-info
Recent News http://www.otcmarkets.com/stock/ISRG/news
Financials http://www.otcmarkets.com/stock/ISRG/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ISRG/filings
Short Sales http://www.otcmarkets.com/stock/ISRG/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ISRG/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ISRG/research
Summary http://finance.yahoo.com/q?s=ISRG
Historical Prices http://finance.yahoo.com/q/hp?s=ISRG+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ISRG
Basic Chart http://finance.yahoo.com/q/bc?s=ISRG+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ISRG+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ISRG+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ISRG+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ISRG+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ISRG+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ISRG+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ISRG+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ISRG+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ISRG+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ISRG
Balance Sheet http://finance.yahoo.com/q/bs?s=ISRG
Cash Flow http://finance.yahoo.com/q/cf?s=ISRG+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ISRG
Market Watch http://www.marketwatch.com/investing/stock/ISRG
Bloomberg http://www.bloomberg.com/quote/ISRG:US
Morningstar http://quotes.morningstar.com/stock/s?t=ISRG
Bussinessweek http://investing.businessweek.com/research/st...icker=ISRG
Barchart http://www.barchart.com/quotes/stocks/ISRG
OTC Short Report http://otcshortreport.com/index.php?index=ISRG
Investopedia http://www.investopedia.com/markets/stocks/ISRG/?wa=0

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Clarins Dazzles Austin with Skin Longevity Event

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

BAIC FOTON Eyes African Market with Strategic Moves

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...